MARKETS

LiveTV

Gold Rate

Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Natco Pharma L Natco Pharma Ltd. | BSE 849.00 3.90 (0.46%) | NSE 846.95 1.35 (0.16%) | Trade | Add

BSE Live

Feb 10, 15:51

849.00 3.90 (0.46%)

Volume

AVERAGE VOLUME

5-Day

35,646

10-Day

35,145

30-Day

51,556

35,077

Prev. Close

845.10
Open Price

850.20

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
846.70 (250)

NSE Live

Feb 10, 15:52

846.95 1.35 (0.16%)

Volume

AVERAGE VOLUME

5-Day

551,023

10-Day

460,908

30-Day

550,388

447,090

Prev. Close

845.60
Open Price

848.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
846.95 (526)

Company Facts - Natco Pharma

Registered Address

NATCO House, Road # 2,
Banjara Hills,,
Hyderabad
Telangana
500034

Tel: 040-23547532
Fax: 040-23548243
Email: investors@natcopharma.co.in
Website: http://www.natcopharma.co.in
Group:

Registrars

Venture Capital & Corporate Investments Pvt. Ltd. “Aurum”, Door No.4-50/P-II/57/4F & 5F, Plot No.57,
Hyderabad - 500032
Telangana

Tel: 040-23818475, 23868257, 35164940
Fax:
Email: investor.relations@vccipl.com
Website: https://www.vccipl.com

Management - Natco Pharma

Name	Designation
V C Nannapaneni	Chairman & Managing Director
P S R K Prasad	Director & Exe. VP (Corp. Engg. Services)
D Vijaya Bhaskar	Independent Director
Kantipudi Suma	Independent Director
Lakshminarayana Bolisetty	Independent Director

Name	Designation
Rajeev Nannapaneni	Vice Chairman & CEO
D Linga Rao	Director & President (Tech. Affairs)
A D M Chavali	Independent Director
Nitin Jain	Independent Director

Natco Pharma Ltd.

Company Facts - Natco Pharma

Management - Natco Pharma

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches